Community Health Systems (CYH) Competitors

Lexeo Therapeutics (NASDAQ:LXEO) and Community Health Systems (NYSE:CYH) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, community ranking, earnings, valuation and risk.

Do insiders and institutionals have more ownership in LXEO or CYH?

60.7% of Lexeo Therapeutics shares are held by institutional investors. Comparatively, 85.0% of Community Health Systems shares are held by institutional investors. 9.9% of Community Health Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Is LXEO or CYH more profitable?

Lexeo Therapeutics has a net margin of 0.00% compared to Lexeo Therapeutics' net margin of -0.99%. Community Health Systems' return on equity of 0.00% beat Lexeo Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lexeo Therapeutics	N/A	N/A	N/A
Community Health Systems	-0.99%	-5.51%	-0.98%

Does the media favor LXEO or CYH?

In the previous week, Community Health Systems had 6 more articles in the media than Lexeo Therapeutics. MarketBeat recorded 20 mentions for Community Health Systems and 14 mentions for Lexeo Therapeutics. Community Health Systems' average media sentiment score of 0.57 beat Lexeo Therapeutics' score of 0.32 indicating that Lexeo Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lexeo Therapeutics	4 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Community Health Systems	2 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

Which has higher earnings & valuation, LXEO or CYH?

Lexeo Therapeutics has higher earnings, but lower revenue than Community Health Systems.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lexeo Therapeutics	$650K	633.65	-$66.39M	N/A	N/A
Community Health Systems	$12.49B	0.04	-$133M	-$0.95	-3.57

Does the MarketBeat Community believe in LXEO or CYH?

Community Health Systems received 539 more outperform votes than Lexeo Therapeutics when rated by MarketBeat users. However, 100.00% of users gave Lexeo Therapeutics an outperform vote while only 53.27% of users gave Community Health Systems an outperform vote.

Company	Underperform	Outperform
Lexeo Therapeutics	Outperform Votes 6 100.00%	Underperform Votes No Votes
Community Health Systems	Outperform Votes 545 53.27%	Underperform Votes 478 46.73%

Do analysts prefer LXEO or CYH?

Lexeo Therapeutics currently has a consensus target price of $20.80, indicating a potential upside of 66.40%. Community Health Systems has a consensus target price of $4.05, indicating a potential upside of 19.47%. Given Community Health Systems' stronger consensus rating and higher possible upside, equities analysts plainly believe Lexeo Therapeutics is more favorable than Community Health Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lexeo Therapeutics	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
Community Health Systems	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Lexeo Therapeutics beats Community Health Systems on 10 of the 15 factors compared between the two stocks.